GlassScriptPhysician profile
Bhavik Khatri
NPI 1457643298
$25,914.44
in general payments reported to CMS, 2019-2025
47 companies · $5,325 in 2025
The $5,325 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $578 · 2021: $6,108 · 2022: $4,253 · 2023: $4,584 · 2024: $5,066 · 2025: $5,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $10.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,964.51 |
| Education | $10.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $3,522.91 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,840.41 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,742.55 | 2020-2025 | Farxiga, Wainua, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $1,405.99 | 2021-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $1,369.30 | 2020-2025 | Nexletol, Nexlizet |
| Novo Nordisk INC | $1,295.35 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $1,245.36 | 2020-2025 | |
| Amgen INC. | $1,178.87 | 2020-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,095.85 | 2020-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $974.75 | 2021-2025 | Verquvo, Winrevair |
| Actelion Pharmaceuticals US, INC. | $757.35 | 2021-2024 | Uptravi, Opsumit |
| Abbott Laboratories | $745.98 | 2021-2025 | I-Stat, Gallant, Jot Dx |
| Impulse Dynamics (USA) INC. | $718.11 | 2022-2024 | Optimizer, Optimizer |
| Pfizer INC. | $666.69 | 2021-2025 | |
| Boston Scientific Corporation | $651.68 | 2022-2025 | Watchman Flx, Ekosonic |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $597.57 | 2020-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $525.15 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $509.67 | 2023-2025 | Amvuttra, Onpattro |
| Irhythm Technologies, INC. | $474.97 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Bardy Diagnostics, INC. | $403.32 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $354.21 | 2024 | Arcalyst |
| Heartflow, INC. | $333.75 | 2022-2025 | |
| Edwards Lifesciences Corporation | $321.31 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Baxter Healthcare | $307.01 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Amarin Pharma, INC. | $296.69 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $279.39 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $229.96 | 2022-2025 | Nimbl, Flexitouch Plus |
| Kiniksa Pharmaceuticals, LTD. | $225.74 | 2021-2023 | Arcalyst |
| Inari Medical, INC. | $210.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $183.83 | 2022-2023 | Cleviprex, Kengreal |
| Recor Medical INC | $183.23 | 2024 | Paradise Renal Denervation System |
| Biotronik INC. | $166.76 | 2023 | Biomonitor |
| Scpharmaceuticals INC. | $162.43 | 2025 | |
| Bridgebio Pharma, INC. | $153.95 | 2025 | Attruby |
| Emd Serono, INC. | $138.16 | 2025 | Mavenclad |
| Kestra Medical Technology Services, INC. | $128.07 | 2024 | Assure Wcd |
| Medtronic, INC. | $103.83 | 2025 | Endurant Iis, Venaseal |
| Philips North America LLC | $97.98 | 2023 | |
| Lundbeck LLC | $67.20 | 2020 | |
| Lilly USA, LLC | $51.98 | 2025 | Zepbound, Mounjaro |
| Agepha Pharma Fz LLC | $38.76 | 2025 | Lodoco |
| Atricure, INC. | $36.96 | 2024 | |
| Medicomp INC | $31.19 | 2022 | |
| Cleerly, INC. | $27.96 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Arbor Pharmaceuticals, INC. | $23.18 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.99 | 2021 | |
| Snap Diagnostics LLC | $17.14 | 2024 | Snap Diagnostics Study |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavik Khatri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.